Characteristic features of urinary calcium excretion and osteoporosis risk factors in patients with urolithiasis


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Relevance. The prevalence of urolithiasis and osteoporosis (OP) indicates that these diseases may be found concurrently in the same patient. The detection of risk factors for OP and disorders of calcium metabolism in patients with urolithiasis is of interest in the context of primary stone formation and metaphylaxis. Aim. To identify risk factors for osteoporosis and disorders of calcium metaboIism in patients with uroIithiasis. Materials and methods. Osteoporosis risk factors were studied in 45 urolithiasis patients undergoing surgical treatment. Patients were asked to fill out the osteoporosis risk factor questionnaire, and urinary calcium excretion was measured in 24-h coIIections. Results Risk factors for osteoporosis were detected in 20 (44.4%) uroIithiasis patients. Patients with osteoporosis risk factors identified by the questionnaire were statistically significantly older (p=0.032). Osteoporosis risk factors were found in 20% of patients with newly diagnosed urolithiasis and 24.4% of patients with recurrent urolithiasis. The study patients showed increased urinary calcium excretion and decreased diuresis. The negative correlation between urinary calcium excretion and 24-h diuresis was greater in patients who had than in those who did not have osteoporosis. Conclusion. An increase in urinary calcium excretion and a decrease in diuresis can be a predisposing factor for the recurrence of urolithiasis. In patients with risk factors for osteoporosis, it can provide a rationale for administering drugs aimed at preventing stone formation (thiazide diuretics).

Texto integral

Acesso é fechado

Sobre autores

L. Demidko

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: kIubnika47@yandex.ru
Ph.D. Student at the Clinic of Urology

V. Rudenko

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: rudenko-vadim@rambIer.ru
Dr.Med.Sci., Prof. at the Department of Urology

V. Grigoryan

Clinic of Urology, I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: doctor-grigoryan@maiI.ru

Yu. Demidko

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: demidko1@maiI.ru
Dr.Med.Sci., Physician at the Clinic of Urology

M. Enikeev

I.M. Sechenov First MSMU ofMinzdrav ofRussia (Sechenov University)

Email: enikmic@maiI.ru
Dr.Med.Sci., Professor at the Department of Urology

Zh. Inoyatov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: inoyat@yandex.ru
Physician at the Clinic of Urology

M. Amosova

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: amosov-av@yandex.ru
Ph.D. Student at the Department of Endocrinology

Bibliografia

  1. Trinchieri A.C.G. et al. Epidemiology in Stone Disease, Segura J.W., Khoury S., Pak C.Y., Preminger G.M., Tolley D. Eds. Health Publications: Paris. 2003 r
  2. Руденко В.И., Семенякин И.В., Малхасян В.А., Гаджиев Н.К. Российские клинические рекомендации. Мочекаменная болезнь. Урология. 2017;Приложение 2:30-63
  3. Türk C., Neisius A., Petrik A., Seitz C., Skolarikos A., Tepeler A., Thomas K. EAU Guidelines. 2017.
  4. Arrabal-Marti'n M., Cano-Garci'a M.C., Arrabal-Polo M.Â., Domi'nguez-Amillo A., Canales-Casco N., de la Torre-Trillo J., Cozar-Olmo J.M. Etiopathogenic factors of the different types of urinary litiasis. Arch Esp Urol. 2017;70(1):40-50.
  5. Taylor E.N., Feskanich D., Paik J.M., Curhan G.C. Nephrolithiasis and Risk of Incident Bone Fracture. J. Urol. 2016;195(5):1482-1486.
  6. Yasui T., Okada A., Hamamoto S., Ando R., Taguchi K., Tozawa K., Kohri K. Pathophysiology-based treatment of urolithiasis. Int J. Urol. 2017;24(1):32-38.
  7. Kozyrakis D., Paridis D., Karatzas A., Soukias G., Dailiana Z. Do Calcium Supplements Predispose to Urolithiasis? Curr Urol Rep. 2017;18(3):17.
  8. Leslie S.W., Taneja A. Hypercalciuria. StatPearls Publishing, 2018 r.
  9. US National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. 2010.
  10. WHO Scientific Group on the Prevention and Management of Osteoporosis. report of a WHO scientific group (WHO Technical Report series;921). Geneva: 6.н., 2000.
  11. MedCalc Statistical Software version 17.0.4 (MedCalc Software bvba, Ostend, Belgium, https://www.medcalc.org и 2017).
  12. Мельниченко Г.А., Удовиченко О.В., Шведова А.Е. Эндокринология. М.: Практическая медицина, 2012

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies